Response evaluation using RECIST and CHOI criteria in patients with well-differentiated pancreatic neuroendocrine tumors (pNET) treated with sunitinib or everolimus

被引：0
|
作者：
Hentic, Olivia
Dreyer, Chantal
Zappa, Magaly
Hammel, Pascal
Mateescu, Cristian
Bouattour, Mohamed
Faivre, Sandrine J.
Ruszniewski, Philippe
Raymond, Eric
机构：
[1] Beaujon Univ Hosp, Dept Gastro Enterol, Clichy, France
[2] Beaujon Univ Hosp, Dept Med Oncol, Clichy, France
[3] Beaujon Univ Hosp, Dept Radiol, Clichy, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14660
引用
收藏
页数：1
相关论文
共 50 条
  • [1] RESPONSE EVALUATION USING RECIST AND CHOI CRITERIA IN PATIENTS WITH WELL-DIFFERENTIATED PANCREATIC NEUROENDOCRINE TUMORS (PNET) TREATED WITH SUNITINIB OR EVEROLIMUS
    Dreyer, C.
    Hentic, O.
    Zappa, M.
    Hammel, P.
    Bouattour, M.
    Mateescu, C.
    Faivre, S.
    Ruszniewski, P.
    Raymond, E.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 379 - 379
  • [2] Recist versus Choi Criteria Response Assesment in Patients with Advanced Pancreatic Neuroendocrine Tumor (PNET) Treated with Sunitinib
    Solis Hernandez, M. P.
    Calvo-Temprano, D.
    Jimenez-Fonseca, P.
    Faez, L.
    Ruiz, A. L.
    Rodriguez, D.
    Sanchez, M. L.
    Li, W.
    Fernandez Arrojo, S.
    Rodriguez, A.
    Uriol, E.
    Carmona-Bayonas, A.
    Menendez Prieto, M. D.
    Vieitez, J. M.
    [J]. NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 133 - 133
  • [3] Angiogenic profiling in patients with advanced well-differentiated pancreatic neuroendocrine tumors treated with everolimus
    Cella, C. A.
    Spada, F.
    Galdy, S.
    Frezza, A. M.
    Catapano, M.
    Funicelli, L.
    Calleri, A.
    Zorzino, L.
    Mancuso, P.
    Radice, D.
    Fazio, N.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S449 - S449
  • [4] Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib
    Nicola Fazio
    Matthew Kulke
    Brad Rosbrook
    Kathrine Fernandez
    Eric Raymond
    [J]. Targeted Oncology, 2021, 16 : 27 - 35
  • [5] Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib
    Fazio, Nicola
    Kulke, Matthew
    Rosbrook, Brad
    Fernandez, Kathrine
    Raymond, Eric
    [J]. TARGETED ONCOLOGY, 2021, 16 (01) : 27 - 35
  • [6] The Efficacy and Safety of Sunitinib in Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
    不详
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (12) : 10 - 11
  • [7] The Efficacy and Safety of Sunitinib in Patients With Advanced Well-differentiated Pancreatic Neuroendocrine Tumors
    Raymond, Eric
    Kulke, Matthew
    Qin, Shukui
    Schenker, Michael
    Cubillo, Antonio
    Lou, Wenhui
    Tomasek, Jiri
    Thiis-Evensen, Espen
    Xu, Jianming
    Racz, Karoly
    Croitoru, Adina
    Khasraw, Mustafa
    Sedlackova, Eva
    Borbath, Ivan
    Ruff, Paul
    Oberstein, Paul
    Ito, Tetsuhide
    Fernandez, Kathrine
    Rosbrook, Brad
    Fazio, Nicola
    [J]. PANCREAS, 2017, 46 (03) : 435 - 435
  • [8] Radiological Changes in the Treatment of Pancreatic Neuroendocrine Tumors (PNET) with Sunitinib: RECIST vs CHOI Criteria. CRIPNET-GETNE Study
    Solis-Hernandez, M. P.
    Carmona-Bayonas, A.
    Calvo-Temprano, D.
    Nunez, B.
    Custodio, A.
    Alonso, T.
    Matos, I
    Benavent, M.
    Lopez, C.
    Sanchez Canovas, M.
    Viudez, A.
    Garcia-Carbonero, R.
    Grande, E.
    Capdevila, J.
    Jimenez-Fonseca, P.
    [J]. NEUROENDOCRINOLOGY, 2017, 105 : 174 - 174
  • [9] Sequential Everolimus and Sunitinib Treatment in Pancreatic Metastatic Well-Differentiated Neuroendocrine Tumors Resistant to Prior Treatments
    Angelousi, A.
    Kampel, K.
    O'Toole, D.
    Kaltsatoy, M.
    Boutzios, G.
    Alexandraki, K.
    Kaltsas, G.
    De Herder, W.
    [J]. NEUROENDOCRINOLOGY, 2016, 103 : 77 - 77
  • [10] The efficacy and safety of sunitinib in patients with advanced well-differentiated pancreatic neuroendocrine tumors.
    Raymond, Eric
    Kulke, Matthew H.
    Qin, Shukui
    Schenker, Michael
    Cubillo, Antonio
    Lou, Wenhui
    Tomasek, Jiri
    Thiis-Evensen, Espen
    Xu, Jianming
    Racz, Karoly
    Croitoru, Adina E.
    Khasraw, Mustafa
    Sedlackova, Eva
    Borbath, Ivan
    Ruff, Paul
    Oberstein, Paul Eliezer
    Ito, Tetsuhide
    Fernandez, Kathrine C.
    Rosbrook, Brad
    Fazio, Nicola
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
12345